Method-dependent changes in "HDL-cholesterol" with recombinant apolipoprotein A-I(Milano) infusion in healthy volunteers. 2002

Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016632 Apolipoprotein A-I The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. Apo A-I,Apo A-1,Apo A-I Isoproteins,Apo A1,Apo AI,ApoA-1,ApoA-I,Apolipoprotein A-1,Apolipoprotein A-I Isoprotein-2,Apolipoprotein A-I Isoprotein-4,Apolipoprotein A-I Isoproteins,Apolipoprotein A1,Apolipoprotein AI,Apolipoprotein AI Propeptide,Pro-Apo A-I,Pro-Apolipoprotein A-I,Proapolipoprotein AI,Apo A I Isoproteins,Apolipoprotein A 1,Apolipoprotein A I,Apolipoprotein A I Isoprotein 2,Apolipoprotein A I Isoprotein 4,Apolipoprotein A I Isoproteins,Pro Apo A I,Pro Apolipoprotein A I

Related Publications

Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
January 1998, Atherosclerosis,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
November 1994, Biochemical Society transactions,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
February 1990, Biochimica et biophysica acta,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
November 2004, Current cardiology reports,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
May 2002, Circulation research,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
August 2005, Atherosclerosis,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
October 1990, Rinsho byori. The Japanese journal of clinical pathology,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
June 2010, Biochemistry,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
March 1998, Circulation,
Thomas G Cole, and William L Nowatzke, and Charles L Bisgaier, and Brian R Krause
January 2016, European heart journal. Cardiovascular pharmacotherapy,
Copied contents to your clipboard!